CYP7A1;cytochrome P450 family 7 subfamily A member 1;CYP7;cytochrome P450, subfamily VIIA (cholesterol 7 alpha-monooxygenase), polypeptide 1;cytochrome P450, family 7, subfamily A, polypeptide 1
RBM6;RNA binding motif protein 6;DEF-3;3G2;NY-LU-12;g16;DEF3
NID1;nidogen 1;NID;nidogen (enactin);entactin
QDPR;quinoid dihydropteridine reductase;DHPR;PKU2;SDR33C1
FAM159A;family with sequence similarity 159 member A;family with sequence similarity 159, member A;MGC52498
LARGE1;LARGE xylosyl- and glucuronyltransferase 1;LARGE;like-glycosyltransferase;KIAA0609
NAA15;N(alpha)-acetyltransferase 15, NatA auxiliary subunit;NARG1;NMDA receptor regulated 1;TBDN100;NATH;FLJ13340
CHRM3;cholinergic receptor muscarinic 3
SMIM12;small integral membrane protein 12;C1orf212;chromosome 1 open reading frame 212;FLJ90372
polycyclic+aromatic+hydrocarbon
AHR;aryl hydrocarbon receptor;bHLHe76
naphthoflavone
indigoid
tryptophan+metabolite
MT-TW;mitochondrially encoded tRNA tryptophan;MTTW;tRNA tryptophan;trnW
Phenobarbital
CYP2B6;cytochrome P450 family 2 subfamily B member 6;CYP2B;cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6;cytochrome P450, family 2, subfamily B;cytochrome P450, subfamily IIB (phenobarbital-inducible);cytochrome P450, family 2, subfamily B, polypeptide 6;CPB6;CYPIIB6
CITCO
carbaldehyde
clotrimazole
TCPOBOP
dichloropyridyloxy
phenytoin
Bile+acid
BAAT;bile acid-CoA:amino acid N-acyltransferase;bile acid Coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase);bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase);BAT
Lithocholic+acid
chenodeoxycholic+acid
GW4064
Glucocorticoid
GLCCI1;glucocorticoid induced 1;glucocorticoid induced transcript 1;GIG18;FAM117C;TSSN1
cholesterol
CH25H;cholesterol 25-hydroxylase
oxysterol
OSBP;oxysterol binding protein;OSBP1
GW3965
T0901317
paxilline
F(3)methylAA
A12M3;entry withdrawn
acetyl-podocarpic+dimmer
ACAA1;acetyl-CoA acyltransferase 1;acetyl-Coenzyme A acyltransferase 1
oltipraz
phenolic+antioxidant
AAED1;AhpC/TSA antioxidant enzyme domain containing 1;C9orf21;chromosome 9 open reading frame 21
fibrate
WY-14
SEPT14P14;septin 14 pseudogene 14
WY-643
LINC00643;long intergenic non-protein coding RNA 643
dehydroepiandrosterone
SULT2A1;sulfotransferase family 2A member 1;STD;sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1;DHEA-ST
fatty+acid
FABP3;fatty acid binding protein 3;MDGI;FABP11;fatty acid binding protein 11;fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor);fatty acid binding protein 3, muscle and heart;H-FABP;O-FABP
rifampin
rifabutin
hyperforin
paclitaxel
nifedine
adalat
ritonavir
amprenavir
nelfinavir
bosentan
efavirenz
lovastatin
simvastatin
troglitazone
vitamin+E
TTPA;alpha tocopherol transfer protein;AVED;ataxia (Friedreich-like) with vitamin E deficiency;tocopherol (alpha) transfer protein
vitamin+K2
FOXK2;forkhead box K2;ILF;ILF1;interleukin enhancer binding factor 1
avasimibe
carbamazepine
spironolactone
spiro
sulphinpyrazone
topotecan
etoposide
EI24;EI24, autophagy associated transmembrane protein;etoposide induced 2.4 mRNA;etoposide induced 2.4;PIG8;TP53I8;EPG4
Polychlorinated+biphenyl
BPHL;biphenyl hydrolase like;MCNAA;biphenyl hydrolase-like (serine hydrolase);Bph-rp;VACVase
phthalate+momoester
omeprazole
troleandomycin
mifepristone
cyproterone+acetate
IAH1;isoamyl acetate-hydrolyzing esterase 1 homolog;isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)
guggulsterone
RU486
progesterone+analog
PGR;progesterone receptor;PR;NR3C3
vd3
EB1089
KH1060
RO+25-9022
RNY4P25;RNA, Ro-associated Y4 pseudogene 25
vitamin+D+analog
GC;GC, vitamin D binding protein;group-specific component (vitamin D binding protein);DBP;VDBP;hDBP
retinoic+acid
STRA6;stimulated by retinoic acid 6;stimulated by retinoic acid gene 6 homolog (mouse);stimulated by retinoic acid 6 homolog (mouse);FLJ12541
9-cis-retinoic+acid
RARRES2P9;retinoic acid receptor responder 2 pseudogene 9;retinoic acid receptor responder (tazarotene induced) 2 pseudogene 9
dimethoxyflavone
androstane
NR1I3;nuclear receptor subfamily 1 group I member 3;nuclear receptor subfamily 1, group I, member 3;MB67;CAR1;CAR
AGN34
CIS-
RDH11;retinol dehydrogenase 11 (all-trans/9-cis/11-cis);retinol dehydrogenase 11 (all-trans and 9-cis);MDT1;SDR7C1;ARSDR1
high-density+lipoprotein
GPIHBP1;glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1;GPI anchored high density lipoprotein binding protein 1;LOC338328;GPI-HBP1
low-density+lipoprotein
LDLRAD1;low density lipoprotein receptor class A domain containing 1;low density lipoprotein receptor A domain containing 1
ET743
AKR1C4;aldo-keto reductase family 1 member C4;CHDR;aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4);DD4;HAKRA;C11;3-alpha-HSD;CDR;MGC22581
NR3C1;nuclear receptor subfamily 3 group C member 1;GRL;nuclear receptor subfamily 3, group C, member 1;nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor);GR
